Protein kinase Cα mediates the effect of antiarrhythmic peptide on gap junction conductance

Cell Communication and Adhesion

Volumn 8, Issue 4-6, 2001, Pages 257-264

  Dhein, Stefan ^a,b   Weng, Stephan ^a   Grover, Rajiv ^a   Tudyka, Tatjana ^a   Gottwald, Michaela ^a   Schaefer, Thomas ^a   Polontchouk, Lioudmila ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Antiarrhythmic peptide; Connexin43; Gap junction; PKC

Indexed keywords

ACONITINE; ANTIARRHYTHMIC PEPTIDE; BISINDOLYLMALEIMIDE; CARBON 14; CONNEXIN 43; DIMETHYL ETHER; MEMBRANE RECEPTOR; PHOSPHATE; PHOSPHORUS 32; PROTEIN KINASE C ALPHA; PROTEIN KINASE C INHIBITOR; AAP 10; ANTIARRHYTHMIC AGENT; CROSS LINKING REAGENT; DRUG DERIVATIVE; ENZYME INHIBITOR; GUANOSINE DIPHOSPHATE; ISOENZYME; OLIGOPEPTIDE; PRKCA PROTEIN, HUMAN; PROTEIN KINASE C;

ANESTHESIA; ANIMAL CELL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CELL MEMBRANE; CELL MEMBRANE CONDUCTANCE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; ENZYME ACTIVATION; ENZYME BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; GAP JUNCTION; GENETIC TRANSFECTION; GUINEA PIG; HEART MUSCLE CELL; HEART VENTRICLE FIBRILLATION; HELA CELL; HUMAN; HUMAN CELL; INCUBATION TIME; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; TEMPERATURE MEASUREMENT; VOLTAGE CLAMP; ANIMAL; CELL JUNCTION; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; PATCH CLAMP; PROTEIN BINDING; RABBIT; RADIOASSAY;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA;

ACONITINE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CONNEXIN 43; CROSS-LINKING REAGENTS; ENZYME INHIBITORS; GAP JUNCTIONS; GUANOSINE DIPHOSPHATE; GUINEA PIGS; HELA CELLS; HUMANS; ISOENZYMES; MYOCYTES, CARDIAC; OLIGOPEPTIDES; PATCH-CLAMP TECHNIQUES; PROTEIN BINDING; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; RABBITS; RADIOLIGAND ASSAY; RATS;

EID: 0035545357     PISSN: 10615385     EISSN: None     Source Type: Journal    
DOI: 10.3109/15419060109080734     Document Type: Article

References (19)

1. Aonuma, S., et al. 1980. Studies on heart XIX. Isolation of an atrial peptide that improves the rhythmicity of cultured myocardial cell clusters. Chem. Pharm. Bull. (Tokyo) 28:3332-3339.
2. Aonuma, S., et al. 1983. Studies on heart XXII. Inhibitory effect of an atrial peptide on several drug-induced arrhythmias in vivo. Yakugaku Zasshi 103:662-666.
3. Dhein, S., and T. Tudyka. 1995. Antiarrhythmisches Peptid AAP13TT. Deutsches Patentamt, Offenlegungsschrift DE 19500990 A1, Int Patent Class: A61 K 38/08.
4. Dhein, S., et al. 1994. A new synthetic antiarrhythmic peptide reduces dispersion of epicardial activation recovery interval and diminishes alterations of epicardial activation patterns induced by regional ischemia. A mapping study. Naunyn-Schmiedebergs Arch. Pharmacol. 350:174-184.
5. Dhein, S., et al. 1999. Effects of the gap junction uncoupler palmitoleic acid on the activation and repolarization wavefronts in isolated rabbit hearts. Br. J. Pharmacol 128:1375-1384.
6. Grover, R., and S. Dhein. 2001. Structure-activity relationships of novel peptides related to the antiarrhythmic peptide AAP10 which reduce the dispersion of epicardial action potential duration. Peptides 22:1011-1021.
7. Hofmann, J. 1997. The potential for isoenzyme-selective modulation of PKC. FASEB J. 11:649-669.
8. Kashiwada, Y., et al. 1994. New hexahydroxybiphenyl derivatives as inhibitors of protein kinase C. J. Med. Chem. 37:195-200.
9. 90 dispersion and prevents ventricular fibrillation in isolated perfused rabbit hearts. FASEB J. 14:A698.
10. Kohama, Y., et al. 1987. A new antiarrhythmic peptide, N-3-(4-hydroxyphenyl)-propionyl-Pro-Hyp-Gyl-Ala-Gly. Chem. Pharm. Bull. 35:3928-3930.
11. Kwak, B. R., and H. J. Jongsma. 1996. Regulation of cardiac gap junction channel permeability and conductance by several phosphorylating conditions. Mol. Cell. Biochem. 157:93-99.
12. Lau, A. F., et al. 1996. Regulation of connexin 43 function by activated tyrosine protein kinases. J. Bioenerget. Biomembr. 28:359-368.
13. Limbird, L. E. 1996. Cell surface receptors: A short course on theory and methods, 2nd ed., Dordrecht, the Netherlands: Klüwer, p. 1-232.
14. Moreno, A. P., et al. 1994. Human connexin43 gap junction channels: Regulation of unitary conductances by phosphorylation. Circ. Res. 74:1050-1057.
15. Müller, A., et al. 1997. Increase in gap junction conduction by an antiarrhythmic peptide. Eur. J. Pharmacol. 327:65-72.
16. Musil, L. S., et al. 1990. Expression of the gap junction protein connexin43 in embryonic chick lens: Molecular cloning, ultrastructural localization, and post-translational phosphorylation. J. Membr. Biol. 116:163-175.
17. Nagy, J. I., et al. 1997. Selective monoclonal antibody recognition and cellular localization of an unphosphorylated form of connexin43. Exp. Cell Res. 236:127-136.
18. Toullec, D., et al. 1991. The bisindolylmaleimide GF 109203X is a potent selective inhibitor of protein kinase C. J. Biol. Chem. 266:15771-15781.
19. Verrecchia, F., et al. 1999. ATP counteracts the rundown of gap junctional channels of rat ventricular myocytes by promoting protein phosphorylation. J. Physiol. (Lond.) 516:447-459.